BB Biotech’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $219M | Hold |
1,375,229
| – | – | 5.5% | 5 |
|
|
2018
Q4 | $132M | Buy |
1,375,229
+303,856
| +28% | +$29.1M | 4.22% | 8 |
|
|
2018
Q3 | $151M | Hold |
1,071,373
| – | – | 4% | 8 |
|
|
2018
Q2 | $168M | Buy |
1,071,373
+68,934
| +7% | +$10.8M | 4.84% | 9 |
|
|
2018
Q1 | $161M | Sell |
1,002,439
-40,000
| -4% | -$6.44M | 4.46% | 11 |
|
|
2017
Q4 | $172M | Sell |
1,042,439
-50,000
| -5% | -$8.24M | 4.84% | 9 |
|
|
2017
Q3 | $68.1M | Buy |
1,092,439
+185,000
| +20% | +$11.5M | 1.88% | 16 |
|
|
2017
Q2 | $72.3M | Sell |
907,439
-65,000
| -7% | -$5.18M | 2.21% | 14 |
|
|
2017
Q1 | $69.1M | Sell |
972,439
-50,000
| -5% | -$3.55M | 2.26% | 13 |
|
|
2016
Q4 | $52.2M | Hold |
1,022,439
| – | – | 1.93% | 13 |
|
|
2016
Q3 | $47.1M | Buy |
1,022,439
+171,800
| +20% | +$7.91M | 1.66% | 16 |
|
|
2016
Q2 | $25.6M | Buy |
850,639
+16,976
| +2% | +$511K | 1.01% | 22 |
|
|
2016
Q1 | $26.7M | Buy |
833,663
+125,000
| +18% | +$4.01M | 1.06% | 21 |
|
|
2015
Q4 | $41.3M | Buy |
+708,663
| New | +$41.3M | 1.16% | 21 |
|